InvestorsHub Logo
Followers 34
Posts 2568
Boards Moderated 0
Alias Born 07/01/2011

Re: lumpy9200 post# 1002

Thursday, 01/23/2020 9:43:02 AM

Thursday, January 23, 2020 9:43:02 AM

Post# of 1612
We have a lot of time for this cancer drug to produce big earnings for the company...

From the news release of this morning:

The company also said the U.S. Patent and Trademark Office granted a patent for coverage for important elements of ALT-702 cancer immunotherapy product candidate. The issued patent will expire no earlier than 2034.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALT News